Nurix Therapeutics Inc (NRIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
| 11-2020 | 08-2020 | 05-2020 | 02-2020 | 11-2019 | |
| Sales | 6,689 | 4,085 | 4,182 | 2,864 | 0 |
| Gross Profit | 6,689 | 4,085 | 4,182 | 2,864 | N/A |
| Operating Expenses | 26,697 | 23,277 | 17,412 | 15,417 | 0 |
| Operating Income | -20,008 | -19,192 | -13,230 | -12,553 | N/A |
| Other Income | 135 | 675 | 223 | 173 | 0 |
| Pre-tax Income | -19,873 | -18,517 | -13,007 | -12,380 | 0 |
| Income Tax | 41 | N/A | -20,587 | 11 | N/A |
| Net Income Continuous | -19,914 | -18,517 | 7,580 | -12,391 | N/A |
| Net Income | $-19,914 | $-18,517 | $7,580 | $-12,391 | $N/A |
| EPS Basic Total Ops | -0.20 | -1.09 | 2.03 | -3.50 | N/A |
| EPS Basic Continuous Ops | -0.20 | -1.09 | 2.03 | -3.50 | N/A |
| EPS Diluted Total Ops | 0.29 | -1.09 | 1.54 | -3.50 | N/A |
| EPS Diluted Continuous Ops | 0.29 | -1.09 | 1.54 | -3.50 | N/A |
| EBITDA(a) | $-19,221 | $-18,562 | $-12,693 | $-12,054 | $N/A |